Clinical And Translational Medicine SCISCIE

Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

Clinical and Translational Medicine (CTM) 是一本经过同行评审的国际开放获取期刊，旨在促进和加速将临床前研究转化为临床应用以及基础科学家和临床科学家之间的交流。该杂志强调新生物技术、生物材料、生物工程、疾病特异性生物标志物、细胞和分子医学、组学科学、生物信息学、应用免疫学、分子成像、药物发现和开发以及监管和卫生政策的临床潜力和应用。该杂志专注于从长凳到床边的方法，有利于产生与患者和疾病相关的假设和问题的研究和临床观察，并指导细胞和分子医学的研究。临床和转化医学欢迎临床医生、研究人员、政策制定者和行业提交意见。

该刊已被国际权威数据库SCI、SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映Multiple领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2022年影响因子为10.6，平均审稿速度为4 Weeks，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。